Original Research Obstetrics| Volume 214, ISSUE 1, P113.e1-113.e7, January 2016

Neurodevelopmental outcome at 2 years in twin-twin transfusion syndrome survivors randomized for the Solomon trial

Published:August 19, 2015DOI:


      The preferred treatment for twin-twin transfusion syndrome is fetoscopic laser coagulation of inter-twin vascular anastomoses on the monochorionic placenta. Severe postoperative complications can occur when inter-twin vascular anastomoses remain patent including twin-anemia polycythemia sequence or recurrent twin-twin transfusion syndrome. To minimize the occurrence of residual anastomoses, a modified laser surgery technique, the Solomon technique, was developed in which the entire vascular equator is coagulated. In the Solomon randomized controlled trial (NTR1245), the Solomon technique was associated with a significant reduction in twin-anemia polycythemia sequence and recurrence of twin-twin transfusion syndrome when compared with the standard laser surgery technique. Although a significant improvement in perinatal outcome was shown after the Solomon technique, the clinical importance should also be ascertained with long-term follow-up evaluation of the surviving children.


      The purpose of this study was to compare the long-term neurodevelopmental outcome in surviving children with twin-twin transfusion syndrome who were included in the Solomon randomized trial and treated with either the Solomon technique or standard laser surgery technique.

      Study Design

      Routine standardized follow-up evaluation in survivors, at least 2 years after the estimated date of delivery, was performed at 2 of the 5 centers that participated in the Solomon trial: Buzzi Hospital Milan (Italy) and Leiden University Medical Center (The Netherlands). The primary outcome of this follow-up study was survival without long-term neurodevelopmental impairment at age 2 years. Neurodevelopmental impairment was defined as cerebral palsy, cognitive and/or motor development score of <85, bilateral blindness, or deafness. Cognitive and motor development was evaluated with the use of Bayley-III. All analyses per fetus, neonate, or child were conducted with the generalized estimated equation module to account for the effect that observations between co-twins are not independent.


      The primary outcome (survival without neurodevelopmental impairment) was detected in 95 of 141 cases (67%) in the Solomon group and in 99 of 146 cases (68%) in the standard group (P = .92). Neurodevelopmental impairment in long-term survivors who were included for follow-up evaluation was detected in 12 of 107 cases (11%) in the Solomon and in 10 of 109 cases (9%) in the standard group (P = .61). Neurodevelopmental impairment was due to cerebral palsy in 1 case (1%; spastic unilateral) in the Solomon group and in 2 cases (2%; spastic unilateral and spastic bilateral) in the standard group (P = .58). Cognitive development <85 cases was detected in 2 of 105 children (2%) in the Solomon group and in 6 of 106 children (6%) in the standard group (P = .23). Motor development <85 occurred in 8 of 103 children (8%) in the Solomon group and 3 of 104 children (3%) in the standard group (P = .23).


      We found no difference in survival without neurodevelopmental impairment between the Solomon and standard laser techniques. In view of the reduction of short-term complications and the absence of increased adverse long-term effects, these data support the use of the Solomon technique in the treatment of twin-twin transfusion syndrome.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Slaghekke F.
        • Lopriore E.
        • Lewi L.
        • et al.
        Fetoscopic laser coagulation of the vascular equator versus selective coagulation for twin-to-twin transfusion syndrome: an open-label randomised controlled trial.
        Lancet. 2014; 383: 2144-2151
        • Lopriore E.
        • Middeldorp J.M.
        • Oepkes D.
        • Klumper F.J.
        • Walther F.J.
        • Vandenbussche F.P.
        Residual anastomoses after fetoscopic laser surgery in twin-to-twin transfusion syndrome: frequency, associated risks and outcome.
        Placenta. 2007; 28: 204-208
        • Lewi L.
        • Jani J.
        • Cannie M.
        • et al.
        Intertwin anastomoses in monochorionic placentas after fetoscopic laser coagulation for twin-to-twin transfusion syndrome: is there more than meets the eye?.
        Am J Obstet Gynecol. 2006; 194: 790-795
        • Robyr R.
        • Lewi L.
        • Salomon L.J.
        • et al.
        Prevalence and management of late fetal complications following successful selective laser coagulation of chorionic plate anastomoses in twin-to-twin transfusion syndrome.
        Am J Obstet Gynecol. 2006; 194: 796-803
        • Slaghekke F.
        • Lewi L.
        • Middeldorp J.M.
        • et al.
        Residual anastomoses in twin-twin transfusion syndrome after laser: the Solomon randomized trial.
        Am J Obstet Gynecol. 2014; 211: 285.e1-285.e7
        • Slaghekke F.
        • Kist W.J.
        • Oepkes D.
        • et al.
        Twin anemia-polycythemia sequence: Diagnostic criteria, classification, perinatal management and outcome.
        Fetal Diagn Ther. 2010; 27: 181-190
        • Volpe J.J.
        Germinal matrix-intraventricular hemorrhage of the premature infant.
        in: Volpe J.J. Neurology of the newborn. Saunders, Philadelphia1995: 403-463
        • de Vries L.S.
        • Eken P.
        • Dubowitz L.M.
        The spectrum of leukomalacia using cranial ultrasound.
        Behav Brain Res. 1992; 49: 1-6
        • Levene M.I.
        Measurement of the growth of the lateral ventricles in preterm infants with real-time ultrasound.
        Arch Dis Child. 1981; 56: 900-904
        • Lopriore E.
        • Sueters M.
        • Middeldorp J.M.
        • Oepkes D.
        • Vandenbussche F.P.
        • Walther F.J.
        Neonatal outcome in twin-to-twin transfusion syndrome treated with fetoscopic laser occlusion of vascular anastomoses.
        J Pediatr. 2005; 147: 597-602
        • Bayley N.
        Bayley scales of infant and toddler development–third edition.
        Pearson Education, San Antonio (TX)2006
        • Surveillance of Cerebral Palsy in Europe
        Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE).
        Dev Med Child Neurol. 2000; 42: 816-824
        • Palisano R.J.
        • Rosenbaum P.
        • Walter S.
        • Russel D.
        • Wood E.
        • Gauppi B.
        Development and reliability of a system to classify gross motor function in children with cerebral palsy.
        Dev Med Child Neurol. 1997; 39: 214-232
        • Senat M.V.
        • Deprest J.
        • Boulvain M.
        • Paupe A.
        • Winer N.
        • Ville Y.
        Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome.
        N Engl J Med. 2004; 351: 136-144
        • Salomon L.J.
        • Ortqvist L.
        • Aegerter P.
        • et al.
        Long-term developmental follow-up of infants who participated in a randomized clinical trial of amniocentesis vs laser photocoagulation for the treatment of twin-to-twin transfusion syndrome.
        Am J Obstet Gynecol. 2010; 203: 444-447
        • Banek C.S.
        • Hecher K.
        • Hackeloer B.J.
        • Bartmann P.
        Long-term neurodevelopmental outcome after intrauterine laser treatment for severe twin-twin transfusion syndrome.
        Am J Obstet Gynecol. 2003; 188: 876-880
        • Graef C.
        • Ellenrieder B.
        • Hecher K.
        • Hackeloer B.J.
        • Huber A.
        • Bartmann P.
        Long-term neurodevelopmental outcome of 167 children after intrauterine laser treatment for severe twin-twin transfusion syndrome.
        Am J Obstet Gynecol. 2006; 194: 303-308
        • Graeve P.
        • Banek C.
        • Stegman-Woessner G.
        • Maschke C.
        • Hecher K.
        • Bartmann P.
        Neurodevelopmental outcome at 6 years of age after intrauterine laser therapy for twin-twin transfusion syndrome.
        Acta Paediatr. 2012; 101: 1200-1205
        • Lenclen R.
        • Ciarlo G.
        • Paupe A.
        • Bussieres L.
        • Ville Y.
        Neurodevelopmental outcome at 2 years in children born preterm treated by amnioreduction or fetoscopic laser surgery for twin-to-twin transfusion syndrome: comparison with dichorionic twins.
        Am J Obstet Gynecol. 2009; 201: 291-295
        • McIntosh J.
        • Meriki N.
        • Joshi A.
        • et al.
        Long term developmental outcomes of pre-school age children following laser surgery for twin-to-twin transfusion syndrome.
        Early Hum Dev. 2014; 90: 837-842
        • Anderson P.J.
        • De Luca C.R.
        • Hutchinson E.
        • Roberts G.
        • Doyle L.W.
        • and the Victorian Infant Collaborative Group
        Underestimation of developmental delay by the new Bayley-III scale.
        Arch Pediatr Adolesc Med. 2010; 164: 352-356
        • Vohr B.
        • Stephens B.E.
        • Higgins R.D.
        • et al.
        Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes.
        J Pediatr. 2012; 161: 222-228.e3
        • Van Klink J.M.
        • Koopman H.M.
        • van Zwet E.W.
        • et al.
        Improvement in neurodevelopmental outcome in survivors of twin-twin transfusion syndrome treated with laser surgery.
        Am J Obstet Gynecol. 2014; 210: 540.e1-540.e7